NEW YORK (AP) — Shares of respiratory drug maker KaloBios Pharmaceuticals are inching higher on the first day of trading.
KaloBios Pharmaceuticals Inc. says its initial public offering of 8.8 million shares priced at $8 per share. The company's stock is now trading on the Nasdaq Global Market under the ticker symbol "KBIO." In early trading the stock gain 9 cents to $8.09.
The underwriters of the offering will have the option to buy another 1.3 million shares to cover any over allotments.
In January KaloBios said it intended to sell 3.9 million shares for $12 to $14 per share.
The company is based in South San Francisco, Calif., and it is studying antibacterial drugs and treatments for cystic fibrosis and blood cancers.
Homemade Gunpowder from What? - Bearing Arms - Video
Ann Coulter - How To Write A New York Times Op-Ed In Three Easy Steps
How to Write a New York Times Op-Ed in Three Easy Steps | Human Events
Megyn Kelly gets angry: Why don’t the left’s “civility” rules apply to Black Lives Matter protesters? - Hot Air
Chris Versace - The Trade-offs in Owning Stocks vs. ETFs
Protestors run Mayor Rahm Emanuel off the stage at public budget meeting
If They Won't Fight, Destroy Them | RedState